Significantly reduces the production of Aß by increasing sAPPα in APP-overexpressing CHO cells. In 6-month-old Tg2576 AD mice treated for 8 weeks, it decreases AD-like pathology together and improves cognitive performance. The gene discussed is APP; the disease is Alzheimer disease.